Justices Won’t Tackle Jurisdiction Question In Lipitor Case

Law360 (October 9, 2018, 4:46 PM EDT) -- An antitrust lawsuit by a group of California pharmacies targeting a settlement between Pfizer Inc. and Ranbaxy Inc. over the anti-cholesterol drug Lipitor hit the end of the road Tuesday, with the U.S. Supreme Court declining to take up the pharmacies’ argument that their suit was improperly removed to federal court and then dismissed.

The justices' decision not to take up the case leaves intact a January ruling by the Third Circuit, which said in an unpublished, per curiam opinion that even though a California federal court had mistakenly removed RP Healthcare and its fellow plaintiffs’ lawsuit from state court on...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!